Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Peng, Ying  [Clear All Filters]
2014
Wu Y, Peng Y, Wang Y. An insight into advances in the pathogenesis and therapeutic strategies of spinocerebellar ataxia type 3. Rev Neurosci. 2014.
2015
Yang J, Liu X-X, Fan H, Tang Q, Shou Z-X, Zuo D-M, Zou Z, Xu M, Chen Q-Y, Peng Y, et al. Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis. PLoS One. 2015;10(10):e0140551.
2021
Dong Y, Li X, Fu W, Tian X, Guo G, Peng Y, Zhai Y, Zhao J, Ding Z, Zhao X, et al. Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation. Stem Cell Res. 2021;58:102622.
2022
Liu Y, Lin Z, Peng Y, Jiang Y, Zhang X, Zhu H, Zhang L, Chen J, Shu X, Luo M, et al. Embryonic organizer formation disorder leads to multiorgan dysplasia in Down syndrome. Cell Death Dis. 2022;13(12):1054.
Lan J, Zhou Y, Wang H, Tang J, Kang Y, Wang P, Liu X, Peng Y. Protective Effect of Human Umbilical Cord Mesenchymal Stem Cell Derived Conditioned Medium in a Mutant TDP-43 Induced Motoneuron-Like Cellular Model of ALS. Brain Res Bull. 2022.
2023
Tang J, Kang Y, Zhou Y, Chen Q, Lan J, Liu X, Peng Y. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Res Bull. 2023:110760.